Capecitabine plus oxaliplatin (XELOX) ve
โ
Michel Ducreux; Jaafar Bennouna; Mohamed Hebbar; Marc Ychou; Gรฉrard Lledo; Thier
๐
Article
๐
2010
๐
John Wiley and Sons
๐
French
โ 440 KB
## Abstract A regimen consisting of 5โfluorouracil/leucovorin plus oxaliplatin (FOLFOXโ6) is widely used in France in the firstโline treatment of metastatic colorectal cancer (MCRC). The aim of our study was to demonstrate the nonโinferiority of capecitabine plus oxaliplatin (XELOX) __versus__ FOLF